
Sign up to save your podcasts
Or
Interesting trial this week evaluating a fixed schedule of rituximab vs. a tailored approach to therapy. See you all at ACR this week!
4.9
111111 ratings
Interesting trial this week evaluating a fixed schedule of rituximab vs. a tailored approach to therapy. See you all at ACR this week!
494 Listeners
117 Listeners
3,321 Listeners
1,082 Listeners
119 Listeners
515 Listeners
67 Listeners
5 Listeners
170 Listeners
11 Listeners
0 Listeners
1 Listeners
0 Listeners
5 Listeners
18 Listeners